Potential Role of Thymosin-α1 Adjuvant Therapy for Glioblastoma

Glioblastomas are high-grade, malignant CNS neoplasms that are nearly always fatal within 12 months of diagnosis. Immunotherapy using proinflammatory cytokines such as IL-2 or IL-12 may prolong survival with glioblastoma. Thymosin-α1 (Talpha1) is a thymic hormone and immunemodulator that increase IL...

Descripción completa

Detalles Bibliográficos
Autores principales: Sungarian, Arno, Cielo, Deus, Sampath, Prakash, Bowling, Nathaniel, Moskal, Peter, Wands, Jack R., de la Monte, Suzanne M.
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2810470/
https://www.ncbi.nlm.nih.gov/pubmed/20111737
http://dx.doi.org/10.1155/2009/302084

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2810470/
https://www.ncbi.nlm.nih.gov/pubmed/20111737
http://dx.doi.org/10.1155/2009/302084

Ejemplares similares